BRAINS

(redirected from Bayer Randomised Acute Ischemia Neuroprotectant Study)
Also found in: Legal, Encyclopedia, Wikipedia.

BRAINS

Abbreviation for:
Bayer Randomised Acute Ischemia Neuroprotectant Study
Biochemical Research and Information Study

Clinical trials
Bayer Randomised Acute Ischemia Neuroprotectant Study. A trial assessing the effect of Repinotan, a serotonin agonist (5HT1A)-receptor subtype in managing symptoms of hemispheric ischemia.
 
Conclusions
Improved neurological and functional outcome at 4 weeks and 3 months in treated patients.

Logistics
Randomised, double-blind, multicentre; 240 patients.
Full browser ?